| Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers W Scheper, S Kelderman, LF Fanchi, C Linnemann, G Bendle, ... Nature medicine 25 (1), 89-94, 2019 | 523 | 2019 |
| Cancer neoantigens TN Schumacher, W Scheper, P Kvistborg Annual review of immunology 37 (1), 173-200, 2019 | 514 | 2019 |
| γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia W Scheper, S van Dorp, S Kersting, F Pietersma, C Lindemans, S Hol, ... Leukemia 27 (6), 1328-1338, 2013 | 227 | 2013 |
| RhoB mediates phosphoantigen recognition by Vγ9Vδ2 T cell receptor Z Sebestyen, W Scheper, A Vyborova, S Gu, Z Rychnavska, M Schiffler, ... Cell reports 15 (9), 1973-1985, 2016 | 144 | 2016 |
| γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs C Gründer, S van Dorp, S Hol, E Drent, T Straetemans, S Heijhuurs, ... Blood, The Journal of the American Society of Hematology 120 (26), 5153-5162, 2012 | 103 | 2012 |
| The molecular mechanism of induced pluripotency: a two-stage switch W Scheper, S Copray Stem Cell Reviews and Reports 5, 204-223, 2009 | 85 | 2009 |
| Hunting for clinical translation with innate-like immune cells and their receptors W Scheper, C Gründer, T Straetemans, Z Sebestyen, J Kuball Leukemia 28 (6), 1181-1190, 2014 | 56 | 2014 |
| Cancer immunotherapy using γδT cells: dealing with diversity W Scheper, Z Sebestyen, J Kuball Frontiers in immunology 5, 601, 2014 | 55 | 2014 |
| Identification of a tumor-specific allo-HLA–restricted γδTCR GJJ Kierkels, W Scheper, AD Meringa, I Johanna, DX Beringer, ... Blood advances 3 (19), 2870-2882, 2019 | 42 | 2019 |
| Inhibition of PKA anchoring to A-kinase anchoring proteins impairs consolidation and facilitates extinction of contextual fear memories IM Nijholt, A Ostroveanu, WA Scheper, B Penke, PGM Luiten, ... Neurobiology of learning and memory 90 (1), 223-229, 2008 | 30 | 2008 |
| A liquid biopsy for cancer immunotherapy TN Schumacher, W Scheper Nature Medicine 22 (4), 340-341, 2016 | 28 | 2016 |
| Identification of patient-specific CD4+ and CD8+ T cell neoantigens through HLA-unbiased genetic screens CM Cattaneo, T Battaglia, J Urbanus, Z Moravec, R Voogd, R de Groot, ... Nature biotechnology 41 (6), 783-787, 2023 | 21 | 2023 |
| Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy W Scheper, C Gründer, J Kuball Oncoimmunology 2 (5), e23974, 2013 | 14 | 2013 |
| STAPLER: efficient learning of TCR-peptide specificity prediction from full-length TCR-peptide data BPY Kwee, M Messemaker, E Marcus, G Oliveira, W Scheper, CJ Wu, ... bioRxiv, 2023.04. 25.538237, 2023 | 11 | 2023 |
| Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells GJJ Kierkels, E van Diest, P Hernández-López, W Scheper, ACM de Bruin, ... Molecular Therapy-Methods & Clinical Development 22, 388-400, 2021 | 7 | 2021 |
| Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening Z Moravec, Y Zhao, R Voogd, DR Cook, S Kinrot, B Capra, H Yang, ... Nature Biotechnology, 1-9, 2024 | 3 | 2024 |
| Adding Help to an HLA-A* 24: 02 Tumor-Reactive γδTCR Increases Tumor Control I Johanna, P Hernández-López, S Heijhuurs, W Scheper, L Bongiovanni, ... Frontiers in Immunology 12, 752699, 2021 | 2 | 2021 |
| Mapping the landscape of T cell-recognized neoantigens in cancer patients W Scheper Genes & Immunity 24 (6), 287-288, 2023 | | 2023 |
